Penumbra (PEN) Gross Profit Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 5.02% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.10% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 4.54% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 15.44% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 9.03% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.15% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 17.49% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 1.49% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 8.46% |
| 10 | Penumbra | 12.52 Bn | 11.91 Bn | 253.41 Mn | 18.82% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.82% |
| Dec 31, 2025 | 23.72% |
| Sep 30, 2025 | 21.11% |
| Jun 30, 2025 | 18.67% |
| Mar 31, 2025 | 19.21% |
| Dec 31, 2024 | 18.87% |
| Sep 30, 2024 | 18.65% |
| Jun 30, 2024 | 11.12% |
| Mar 31, 2024 | 17.61% |
| Dec 31, 2023 | 25.63% |
| Sep 30, 2023 | 25.03% |
| Jun 30, 2023 | 36.97% |
| Mar 31, 2023 | 19.73% |
| Dec 31, 2022 | 12.15% |
| Sep 30, 2022 | 12.13% |
| Jun 30, 2022 | 12.58% |
| Mar 31, 2022 | 14.94% |
| Dec 31, 2021 | 16.81% |
| Sep 30, 2021 | 16.93% |
| Jun 30, 2021 | 17.99% |
| Mar 31, 2021 | 18.71% |
| Dec 31, 2020 | 13.96% |
| Sep 30, 2020 | 18.40% |
| Jun 30, 2020 | 8.43% |
| Mar 31, 2020 | 22.64% |
| Dec 31, 2019 | 28.19% |
| Sep 30, 2019 | 30.82% |
| Jun 30, 2019 | 31.33% |
| Mar 31, 2019 | 28.11% |
| Dec 31, 2018 | 29.25% |
| Sep 30, 2018 | 30.83% |
| Jun 30, 2018 | 38.20% |
| Mar 31, 2018 | 35.54% |
| Dec 31, 2017 | 38.69% |
| Sep 30, 2017 | 38.10% |
| Jun 30, 2017 | 35.00% |
| Mar 31, 2017 | 39.82% |